Cardiology (Video)

Sulpizio Cardiovascular Center at UC San Diego Health marks 10 years of care. Explore patients’ experiences and the center’s impact on the community. From transforming cardiovascular medicine in San Diego to new collaborations, the last decade has led to tremendous success for cardiovascular medicine including the establishment of the Cardiovascular Institute. Series: "UC San Diego Health Talks" [Health and Medicine] [Show ID: 37275]

Chuck Murry, MD, PhD shares recent research on using cardiomyocytes to model COVID-19 heart disease. He also discusses current efforts to regenerate the heart and reduce arrhythmias. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37016]

COVID-19 was initially identified as a respiratory disease, but scientists now know that it also affects several other organs in the body, including the heart. Heart damage is a major determinant of COVID-19 related deaths, and even patients who experience only mild COVID-19 symptoms exhibit signs of cardiac dysfunction after recovery. UCSF researchers Todd McDevitt and Bruce Conklin explore how SARS-CoV-2, the virus that causes COVID-19, inflicts damage on heart cells. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 36499]

Deborah K. Lieu, PhD

UC Davis Series: "Women in Science" [Health and Medicine] [Science] [Show ID: 36335]

After a heart attack and triple bypass surgery at age 60, Pat Farrant learned he had an inherited heart condition. He now dedicates his time to raising awareness about heart disease an its warning signs. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36434]

Can we discover new therapies for the heart with stem cells? From finding safer medication to preventing cardiac arrest, experts share the latest in the field of cardiac stem cell research.

Moderated by Anthony DeMaria, MD, UC San Diego

Pat Farrant: Patient Perspective

Deepak Srivastava, MD, Gladstone Institutes: Cellular Reprogramming Approaches for Heart Disease

Mark Mercola, PhD, Stanford University: Induced Pluripotent Stem Cell (iPSC)-derived Cardiomyocytes for Predicting and Removing Drug Cardiotoxicity

Deborah K. Lieu, PhD, UC Davis: The quest for pacemaking cardiomyocytes to engineer biopacemakers Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36336]

Deepak Srivastava, MD

Gladstone Institutes Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36333]

Mark Mercola, PhD

Stanford University Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36334]

Join UC San Diego Vice Chancellor David Brenner, MD and the Cardiovascular Institutes Co-Executive Directors Drs. Michael Madani and Ehtisham Mahmud, for a conversation about how COVID-19 can impact heart healthand how UC San Diego Health is at the forefront of providing care for whatever challenges COVID-19 may present. Series: "UC San Diego Health Talks" [Health and Medicine] [Show ID: 36041]

Dr. Gordon Fung looks at trends of cardiovascular disease in the US and trends in selected states by ethnicity to explore if heart disease and stroke are on the rise in Asians. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 35580]